DarioHealth to Report Financial Results for the Second Quarter 2020 Results on August 12
DarioHealth Corp. (Nasdaq: DRIO) will announce its second quarter financial results for the period ending June 30, 2020, on August 12, 2020. Following the release, a conference call will be held at 9:00 AM EDT, featuring key executives including CEO Erez Raphael and CFO Zvi Ben-David. Participants can join the call using provided dial-in numbers, and a replay will be available shortly after the call until August 26, 2020. DarioHealth specializes in digital therapeutics, enhancing the management of chronic conditions through innovative technology.
- Upcoming conference call for Q2 2020 results may provide insights into business performance.
- DarioHealth is a leader in digital therapeutics, indicating strong market positioning.
- None.
NEW YORK, Aug. 7, 2020 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO) ("DarioHealth" or the "Company"), a pioneer in the global digital therapeutics market, announced it will release its second quarter ended June 30, 2020 financial results on Wednesday, August 12, 2020, and host a conference call at 9:00am Eastern Time.
The call will be hosted by Erez Raphael, Chief Executive Officer, Rick Anderson, President and General Manager of North America, and Zvi Ben-David, Chief Financial Officer.
Conference Call Details
Date: Wednesday, August 12, 2020
Time: 9:00 am EDT
Toll Free: 844-369-8770
International: 862-298-0840
Conference ID: DarioHealth Second Quarter 2020 Earnings Call and Webcast
Webcast: https://www.webcaster4.com/Webcast/Page/2224/36466
Participants are asked to dial-in approximately 10 minutes prior to the start of the event. A replay of the call will be available approximately two hours after completion through August 26, 2020. To listen to the replay, dial 1-877-481-4010 (domestic) or 1-919-882-2331 (international) and use replay passcode 36466. The webcast replay will be available through November 12, 2020.
About DarioHealth Corp.
DarioHealth Corp. (Nasdaq: DRIO) is a leading, global digital therapeutics company revolutionizing the way people with chronic conditions manage their health. By delivering evidence-based interventions that are driven by data, high-quality software and coaching, we empower individuals to make healthy adjustments to their daily lifestyle choices to improve their overall health. Our cross-functional team operates at the intersection of life sciences, behavioral science and software technology to deliver highly engaging therapeutic interventions. Dario is one of the highest-rated diabetes solutions in the market, and its user-centric MyDario™ mobile app is loved by tens of thousands of consumers around the globe. DarioHealth is rapidly moving into new chronic conditions and geographic markets, using a performance-based approach to improve the health of users managing chronic disease. To learn more about DarioHealth and its digital health solutions, please go to: http://mydario.com.
DarioHealth Contact:
Claudia Levi
Content & Communications Manager
claudia@mydario.com
347-767-4220
Investor Relations Contact:
Chuck Padala
chuck@lifesciadvisors.com
+ 646-627-8390
View original content:http://www.prnewswire.com/news-releases/dariohealth-to-report-financial-results-for-the-second-quarter-2020-results-on-august-12-301108320.html
SOURCE DarioHealth Corp.
FAQ
What date will DarioHealth report its Q2 2020 financial results?
What time is the DarioHealth conference call scheduled for?
Who will host the DarioHealth earnings call?
How can I listen to the DarioHealth conference call?
When will the DarioHealth conference call replay be available?
